Feb 3 (Reuters) - Celyad Oncology SA CYAD.BR :
* CELYAD ONCOLOGY PROVIDES FOURTH QUARTER 2022 BUSINESS
UPDATE AND
2023 OUTLOOK
* AS OF DECEMBER 31, 2022, COMPANY ENDED YEAR WITH AN
UNAUDITED
TREASURY POSITION OF EUR 12.4 MILLION ($13.3 MILLION)
* NET CASH BURN DURING Q4 OF 2022 AMOUNTED TO EUR 1.0
MILLION
* PROJECTS ITS EXISTING CASH AND CASH EQUIVALENTS SHOULD BE
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURE
REQUIREMENTS INTO Q4 OF 2023
Source text for Eikon: ID:nGNX4V7SKT
Further company coverage: CYAD.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))